Φορτώνει......
Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review
BACKGROUND: Psychosis is common in Parkinson’s disease-related disorders and is associated with significant morbidity. Pimavanserin is a newly approved treatment for Parkinson’s disease psychosis, but real-world experience with pimavanserin has been limited by small sample sizes and limited assessme...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Drugs Aging |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer International Publishing
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6584229/ https://ncbi.nlm.nih.gov/pubmed/30924099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-019-00655-y |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|